tirzepatide and wegovy vs Wegovy: Differences, Cost, Weight Loss Results F.D.A. Approves New Obesity Drug

If you discover youre pregnant while taking the medication, the immediate step is to stop tirzepatide and contact your healthcare provider as soon as possible

What you actually pay, however, depends almost entirely on one question: are you insured under the statutory health insurance scheme (gesetzliche Krankenversicherung, GKV), do you have private insurance (private Krankenversicherung, PKV), or are you paying out of pocket

$399 / 1st month

Check your formulary proactively rather than finding out at the pharmacy counter

On February 20, 2026, the FDA issued MEDVi a warning letter for misbranding: its website displayed product labeling that implied MEDVi itself compounded the drug, and used claims that implied FDA-approval equivalence to Mounjaro and Zepbound

Mistake #9: Starting tirzepatide without a medical screen for contraindications and risk What goes wrong: Patients focus on the goal (weight loss) and skip the medical reality: tirzepatide has specific warnings and isnt appropriate for everyone